↓ Skip to main content
What is this page? Embed badge

Disposable Bioreactors II

Overview of attention for book
Cover of 'Disposable Bioreactors II'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 186 Fast Single-Use VLP Vaccine Productions Based on Insect Cells and the Baculovirus Expression Vector System: Influenza as Case Study
  3. Altmetric Badge
    Chapter 187 Dynamic Single-Use Bioreactors Used in Modern Liter- and m 3 - Scale Biotechnological Processes: Engineering Characteristics and Scaling Up
  4. Altmetric Badge
    Chapter 188 Orbitally Shaken Single-Use Bioreactors
  5. Altmetric Badge
    Chapter 189 Microbial High Cell Density Fermentations in a Stirred Single-Use Bioreactor
  6. Altmetric Badge
    Chapter 198 An Approach to Quality and Security of Supply for Single-Use Bioreactors
  7. Altmetric Badge
    Chapter 219 Cultivation of Marine Microorganisms in Single-Use Systems
  8. Altmetric Badge
    Chapter 220 Flexible Biomanufacturing Processes that Address the Needs of the Future
  9. Altmetric Badge
    Chapter 233 Therapeutic Human Cells: Manufacture for Cell Therapy/Regenerative Medicine
  10. Altmetric Badge
    Chapter 238 Quorus Bioreactor: A New Perfusion-Based Technology for Microbial Cultivation
  11. Altmetric Badge
    Chapter 244 A Risk Analysis for Production Processes with Disposable Bioreactors
Attention for Chapter 233: Therapeutic Human Cells: Manufacture for Cell Therapy/Regenerative Medicine
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
42 Mendeley
Summary X Dimensions citations
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic Human Cells: Manufacture for Cell Therapy/Regenerative Medicine
Chapter number 233
Book title
Disposable Bioreactors II
Published in
Advances in biochemical engineering biotechnology, August 2013
DOI 10.1007/10_2013_233
Pubmed ID
23934363
Book ISBNs
978-3-64-245157-7, 978-3-64-245158-4
Authors

Christian van den Bos, Robert Keefe, Carmen Schirmaier, Michael McCaman

Abstract

: Human primary cells (e.g. adult stem cells) as well as differentiated cells, including those of the immune system, have been found to be therapeutically useful and free of ethical concerns. Several products have received market authorization and numerous promising clinical trials are underway. We believe that such primary therapeutic cells will dominate the market for cell therapy applications for the foreseeable future. Consequently, production of such cellular products warrants attention and needs to be a fully controlled pharmaceutical process. Thus, where possible, such production should change from manufacture towards a truly scalable industrialized process for both allogeneic and autologous products. Here, we discuss manufacturing aspects of both autogeneic and allogeneic products, review the field, and provide historical context.

View on publisher site
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
 Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Switzerland 2 5%
Netherlands 1 2%
Unknown 39 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 26%
Student > Bachelor 9 21%
Researcher 6 14%
Other 4 10%
Student > Master 4 10%
Other 5 12%
Unknown 3 7%
Readers by discipline Count As %
Agricultural and Biological Sciences 12 29%
Biochemistry, Genetics and Molecular Biology 8 19%
Engineering 5 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Medicine and Dentistry 2 5%
Other 6 14%
Unknown 7 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2014.
All research outputs
#15,298,293
of 22,751,628 outputs
Outputs from Advances in biochemical engineering biotechnology
#113
of 224 outputs
Outputs of similar age
#121,951
of 197,364 outputs
Outputs of similar age from Advances in biochemical engineering biotechnology
#4
of 4 outputs
Altmetric has tracked 22,751,628 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 224 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,364 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.

This page is provided by Altmetric.